StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

InflaRx's shares outstanding was 68M at Jun 30, 2025. For fiscal 2025 it was 67M, up 14.2% from the year before. The highest annual figure on record is 67M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202567M+14.2%
FY2024Dec 31, 202459M+7.2%
FY2023Dec 31, 202355M+24.3%
FY2022Dec 31, 202244M+6.2%
FY2021Dec 31, 202142M+53.8%
FY2020Dec 31, 202027M+4.1%
FY2019Dec 31, 201926M+3.6%
FY2018Dec 31, 201825M+166.7%
FY2017Dec 31, 20179M+398144.8%
FY2016Dec 31, 20160M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 202568M+53.3%
Q2 FY2024Jun 30, 202459M+226688.1%
Q2 FY2023Jun 30, 202357M+228850.3%
Q2 FY2022Jun 30, 202244M–
Q2 FY2021Jun 30, 202144M–
Q2 FY2019Jun 30, 20190M–
Q2 FY2018Jun 30, 20180M–

More InflaRx figures

See a number that looks wrong?